Lynk Pharmaceuticals' partner Formation Bio doses first participant in BLKR201 Phase 1 trial

Antengene granted IND approval in China for ATG-201 in autoimmune disease

Antengene presents first ATG-207 preclinical data at EULAR 2026

Gilead and Lakefront complete Ouro Medicines acquisition to expand autoimmune disease pipeline

Breckenridge launches Tofacitinib Tablets, generic equivalent to Pfizer's Xeljanz

HotSpot Therapeutics presents preclinical data from small molecule IRF5 inhibitor programme at EULAR 2026

Circio and GenAssist announce gene therapy research collaboration for muscle diseases and in vivo cell therapy

CellCarta partners with Sonic Healthcare to commercialise companion diagnostics through Lab Network

Accro Bioscience completes USD50m Series C financing

Mabwell's clinical trial application for 9MW5211 cleared by US FDA

Curocell secures full approval for RIMQARTO to enter CAR-T therapy market

HUTCHMED secures priority review for sovleplenib NDA in China

Johnson & Johnson IMAAVY (nipocalimab-aahu) granted FDA Priority Review as potential treatment for wAIHA

Circio partners with Acuitas to evaluate in vivo CAR-T cell therapy technology

Asgard Therapeutics appoints chief medical officer